| Health / Medical Topics |
Cancer Stemness Kinase Inhibitor BBI503
An orally available cancer cell stemness kinase inhibitor with potential antineoplastic activity. Even though the exact target has not been fully elucidated, BBI503 targets and inhibits one or more pathways involved in cancer stem cell survival. As a result, cancer stem cell (CSC) growth as well as heterogeneous cancer cell growth is inhibited. CSCs, self-replicating cells able to differentiate into heterogeneous cancer cells, appear to be responsible for both tumor relapse and metastasis. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated,…
A malignant cell which may derive from mutations in normal stem cells. Cancer stem cells proliferate and give rise to other malignant…
The use of any device, marker, or other means for the purpose of detecting the presence of a tumor, usually before there…
Systematic investigation into the causes, basic science, detection, and treatment of cancer.
Model systems that predict the occurrence of cancer in a population based on several parameters. These parameters serve as indicators of the…
The probability that exposure to some agent or substance will adversely transform cells to replicate and form a malignant tumor. (EPA Terminology…
